Hormonal replacement theray and uterus carcinomas

Tomasz Opala

eISSN: 2299-0038
ISSN: 1643-8876

Menopause Review/Przegląd Menopauzalny

Current issue Archive Online First About the journal Editorial board Abstracting and indexing Subscription Contact Ethical standards and procedures Special Issues Instructions for authors Publication charge

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

1/2003
vol. 2

Send email

Copy url:

abstract:

Hormonal replacement theray and uterus carcinomas

Tomasz Opala

(Prz Menopauz 2003, 1: 23–26)

Online publish date: 2003/03/28

View full text Get citation

In this article the effects of hormone replacemnt therapy on endometrial cancer risk are reviewed. In pathogenesis of endometrial cancer central role, exept hiperestrogenism and progesteron deficiency, plays FSH, LH, prolactin, insulin, IGF-I as well. Smoking moderates the risk associated with endometrial cancer among women at greatest risk, specifically women who are obese or who use postmenopausal hormones.

keywords:

Hormonal replacement theray and uterus carcinomas

Tomasz Opala

hormonal replacement therapy, endometrial cancer, risk factors